Use of mood stabilizers among patients with schizophrenia, 1994-2001

Psychiatric Services

Volumn 53, Issue 10, 2002, Pages 1212-

  Citrome, Leslie ^a   Jaffe, Ari ^a   Levine, Jerome ^a   Allingham, Baerbel ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LITHIUM; NEUROLEPTIC AGENT; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

AFFECTIVE NEUROSIS; CLINICAL PRACTICE; DATA BASE; HUMAN; MENTAL HEALTH; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SHORT SURVEY;

ANTIPSYCHOTIC AGENTS; COMMUNICATION; HUMANS; MALPRACTICE; MANAGED CARE PROGRAMS; PHYSICIAN-PATIENT RELATIONS; SCHIZOPHRENIA;

EID: 0036787358     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.53.10.1212     Document Type: Short Survey

References (2)

1. Citrome L. Levine J, Allingham B: Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998. Psychiatric Services 51:634-638, 2000
2. McEvov JP, Scheifler PL, Frances A: The Expert Consensus Guideline Series, Treatment of Schizophrenia. Journal of Clinical Psychiatry 60(suppl 11):43, 1999